News by region

  • AI model can detect multiple cognitive diseases from single blood sample

    An AI model detects several neurodegenerative diseases from a single blood sample, researchers at Lund University in Sweden say. Neurodegenerative diseases are conditions in which brain cells progressively deteriorate, such as Alzheimer’s and Parkinson’s. Different conditions can show similar symptoms, making them hard to distinguish, especially in the early stages of cognitive decline. A patient [...]

  • Smart IUD could ‘provide insights we’ve never had before’

    A smart IUD being developed in Oxfordshire could help fertility research and women's healthcare by tracking conditions inside the uterus. Verso Biosense is developing a wireless monitoring device that collects real-time data from inside the uterus, including temperature and oxygen levels. Researchers hope this will shed light on one of medicine's least understood organs. [...]

  • Pharmacierge partners with Tatler to recognise UK’s leading private doctors

    Pharmacierge, the UK’s premier private e-prescription and medication delivery service, has partnered with Tatler to present the Tatler Doctors Guide – an exclusive list of the UK’s leading private clinicians. To be published annually, the guide features the UK’s most renowned clinicians in private medicine, drawing on recommendations from more than 45 private GPs to [...]

  • WHOOP raises US$575m for personalised health platform

    WHOOP has raised US$575m in Series G funding, valuing the company at US$10.1bn as it expands its personalised health platform globally. The Boston-based company said the funding will support international expansion across Europe, the Gulf states, Latin America and Asia, alongside further growth in the US. WHOOP said it now has more than 2.5m members [...]

  • Lucida Medical raises £8.7m for AI-powered prostate cancer diagnostic

    Lucida Medical has raised £8.7m for AI-powered prostate cancer diagnosis from MRI scans, backed by IW Capital and existing investors. Lucida Medical is a Cambridge and health tech company using AI to help clinicians diagnose prostate cancer from MRI scans faster and more accurately. Lucida’s AI-powered diagnostic service is already working within the [...]

  • Women’s hereditary cancer testing: From specialist to self-refer

    Article produced in association with Jeen Health and Spital Clinic Genetic testing for hereditary cancer risk in women has, for much of its clinical history, been available only through a referral pathway involving a GP, a clinical genetics team and a family history review meeting specific risk thresholds. The arrival of direct-access private testing has [...]

  • Leeds Teaching Hospitals secures major NIHR Capital Research Infrastructure funding to accelerate world‑leading research

    Leeds Teaching Hospitals has been awarded £1.5m from the National Institute for Health and Care Research (NIHR) to support the Trust’s ambition to further advance cutting-edge research and enable more patients across the region to benefit from life-changing research. The funding has been awarded to support four initiatives which include pioneering equipment and essential digital [...]

  • Major upgrade for Musgrove Park Hospital’s nuclear medicine department

    A major step forward for diagnostic imaging in Somerset has been reached with the reopening of the Nuclear Medicine department at Musgrove Park Hospital, following a significant refurbishment and the installation of a new state-of-the-art SPECT/CT scanner. Delivered by Ergéa UK in partnership with Somerset NHS Foundation Trust, the redevelopment includes a purpose-built facility with [...]

  • One in four Brits would trust AI over their doctor, research finds

    One in four Brits would trust AI over their doctor if the two gave different medical advice, according to new research. More than half of people are now turning to AI for medical advice, the Medichecks survey revealed, with 55.7 per cent of respondents saying they had already used tools such as ChatGPT, while 95.7 [...]

  • Tom Brady-backed telehealth firm eMed valued at over US$2 billion

    eMed has been valued at over US$2bn after completing a US$200m Series A round, marking a new milestone for the Miami-based digital healthcare startup. Led by AON Consulting, the round’s investors included retired NFL star Tom Brady, who became the company’s chief wellness officer earlier this year, and Linda Yaccarino, former chief executive of X [...]